Vascular Simulations plans to reduce device reliance animal testing and transform device development, demonstration, & training with a new, versatile replication platform.

STONY BROOK, N.Y., Sept. 21, 2018 /PRNewswire/ — Every year in the US alone, 1 million animals are subject to reliance testing, and 92% of successful animal experimentation ends up failing in human trials.1 This disparity is one reason modern medicine needs a more representative testing platform that provides accurate feedback within the device research process. With this exact goal in mind, medical technology company Vascular Simulations releases Replicator PRO™, a realistic vascular replication system at the 2018 Transcatheter Cardiovascular Therapeutics meeting in San Diego, CA. A better alternative to device reliance animal testing, Replicator Pro™ empowers device development, demonstration, and training for engineers, educators, and physicians.

Vascular Simulations introduces Replicator Pro™ – a realistic vascular replication system that accelerates the development and training of interventional devices with confidence. Vascular Simulations plans to reduce animal testing and accelerate device development across all vascular specialties. Catch Replicator PRO™ from Sept. 21-25 at #TCT2018 at booth 2139. Learn more at

Replicator PRO™ is the next platform for medical device validation as it recreates the realistic hemodynamic environment. Through its treated silicone vasculature, Replicator PRO™ provides the necessary tactile feedback for interventional device track and navigation, allowing devices to behave in Replicator PRO™ the same way they would in human vessels. For researchers and engineers, Replicator PRO™ optimizes for device design and performance and provides a more efficient testing platform than modern methods. For physicians and clinical directors, Replicator PRO™ is a versatile training and preparation platform.

Unlike current reliance testing practices, Replicator PRO™ brings the next generation to physician training and preparation and boosts confidence in professionals. “By giving the user the ability to perform a simulated procedure that takes place in the same hemodynamic conditions as it would in real life, there is an added fidelity component to the simulated procedure and it, therefore, makes the educational experience as close to reality as possible,” says Director of Vascular and Endovascular Surgery, Dr. Apostolos Tassiopoulo of Stony Brook Hospital. “In animal reliance testing, you never have the specific anatomy you are trying to treat,” continues Dr. Tassiopoulos, “so Replicator PRO™ offers a much more relevant anatomical and hemodynamic environment.”

Physicians expand their insight with no added risk through the power of Replicator PRO’s realism both through hemodynamic and clinical experience. In addition to matched aortoiliac vasculature, the model includes a 4-chamber silicone heart with a replaceable, physiologically functioning aortic valve. This 3D-printed anatomy works in harmony with the endovascular-responsive terrain and system control unit to give the system its advanced hemodynamics. In addition to replicating the hemodynamic environment, Replicator PRO™ mimics the clinical environment through angiographic compatibility, giving physicians the ability to track and map their procedures. Replicator PRO™ is the next platform for training.

Vascular Simulations masters the art of realism and versatility for the professional user. To improve modern-day testing methods and accelerate medical advancements, Vascular Simulations releases Replicator PRO™, their greatest technology yet. This is an exhibition not to be missed; visit booth #2139 to catch Replicator PRO™ in action.

About Vascular Simulations

Vascular Simulations is a medical technology company based in Stony Brook, NY. Vascular Simulations aspires to provide the most realistic vascular simulations with the fastest delivery to improve healthcare outcomes.

1 “Arguments against animal testing.” Cruelty Free International, n.p., n.d.
/why-we-do-it/arguments-against-animal-testing. Accessed Sep 2018.